0000000000541190
AUTHOR
Smail Hadj-rabia
Mosaic activating mutations in GNA11 and GNAQ are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis
Common birthmarks can be an indicator of underlying genetic disease but are often overlooked. Mongolian blue spots (dermal melanocytosis) are usually localized and transient, but they can be extensive, permanent, and associated with extracutaneous abnormalities. Co-occurrence with vascular birthmarks defines a subtype of phakomatosis pigmentovascularis, a group of syndromes associated with neurovascular, ophthalmological, overgrowth, and malignant complications. Here, we discover that extensive dermal melanocytosis and phakomatosis pigmentovascularis are associated with activating mutations in GNA11 and GNAQ, genes that encode Gα subunits of heterotrimeric G proteins. The mutations were det…
Mutations activatrices de GNA11 et GNAQ en mosaïque dans les phacomatoses pigmento-vasculaires et les taches mongoliques étendues
Introduction Les taches mongoliques, correspondant a une melanocytose dermique, sont frequentes a la naissance mais generalement transitoires. Elles peuvent parfois persister isolement ou en association a des angiomes plans dans les phacomatoses pigmento-vasculaires (types cesioflammea et cesiomarmorata), affections ou nous avons identifie des mutations en mosaique de deux genes de proteines G. Materiel et methodes Huit patients atteints de divers types de phacomatose pigmento-vasculaire et trois presentant une melanocytose dermique persistante etendue ont ete etudies par sequencage cible des genes GNAQ et GNA11 sur ADN de biopsie de peau pigmentee, d’angiome plan, de sang, ou dans un cas d…
Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.
Postzygotic activating mutations of PIK3CA cause a wide range of mosaic disorders collectively referred to as PIK3CA-related overgrowth spectrum (PROS). We describe the diagnostic yield and characteristics of PIK3CA sequencing in PROS. We performed ultradeep next-generation sequencing (NGS) of PIK3CA in various tissues from 162 patients referred to our clinical laboratory and assessed diagnostic yield by phenotype and tissue tested. We identified disease-causing mutations in 66.7% (108/162) of patients, with mutant allele levels as low as 1%. The diagnostic rate was higher (74%) in syndromic than in isolated cases (35.5%; P = 9.03 × 10−5). We identified 40 different mutations and found stro…